Alexion Pharma (ALXN) Soliris patents get review on Amgen (AMGN) challenge at patent office - Bloomberg
Alexion Pharma (NASDAQ: ALXN) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
